Healthcare professionals constantly seek effective solutions to prevent the spread of dangerous pathogens. Well, look no further! NaDCC (sodium dichloroisocyanurate) effervescent disinfection tablets are effective against a broad spectrum of pathogens, including those resistant to antibiotics. They also offer a practical and efficient method for disinfecting medical tools, surfaces, and, if required, linens within healthcare settings.
Hypervirulent Klebsiella pneumoniae (hvKp) ST23 has acquired carbapenemase genes, making it resistant to last-line antibiotics. This combination of hypervirulence and antimicrobial resistance is concerning because hvKp can cause severe infections in healthy individuals and has been shown to spread within and between healthcare facilities.
NaDCC (sodium dichloroisocyanurate) effervescent disinfection tablets could help reduce the contamination and spread of hvKp in healthcare settings by effectively disinfecting surfaces and medical equipment. When dissolved in water, the tablets release HOCl, known for its broad-spectrum antimicrobial activity and effectiveness against bacteria with antimicrobial resistance. Regularly using such disinfection protocols can help mitigate the risk of hvKp transmission, supporting infection control measures and reducing potential outbreaks in healthcare environments.
To support infection preventionists in combating antimicrobial resistance (AMR), particularly against pathogens like hypervirulent Klebsiella pneumoniae, incorporating NaDCC (sodium dichloroisocyanurate) effervescent disinfection tablets into infection prevention protocols is vital. These tablets offer a broad-spectrum disinfection capability that can be effectively integrated into comprehensive infection control programs within healthcare settings.
Key aspects of utilizing NaDCC tablets in infection prevention protocols include:
Preparation and Use: A chlorine solution (1000 ppm) is recommended for pre-disinfection of soiled instruments, requiring one tablet of 1 g of active chlorine per litre. Instruments should be soaked immediately after use for 15 minutes, followed by cleaning. Clean instruments require soaking in a similar concentration for 20 minutes, then rinsing thoroughly and drying. For linen disinfection and general disinfection (surfaces, floors, sinks, equipment), a 0.1% solution is also effective, ensuring all items are soaked for 15 minutes and rinsed thoroughly.[1]
Advantages of NaDCC Tablets: They offer several benefits, such as being safer due to their neutral pH and not dulling high-gloss floor finishes with repeated use, simpler due to exact dosage delivery and eliminating the “measure and pour” guesswork, and sustainable due to their small size, non-hazardous shipping, reduced packaging waste, and savings on storage, shipping, handling, and waste minimization. NaDCC tablets are effective against a wide range of pathogens, including Clostridium difficile spores and Norovirus, meeting OSHA’s Bloodborne Pathogen Standard. Moreover, its sustainable profile — small tablet form, non-hazardous shipping, and reduced packaging waste — aligns with green healthcare practices.
Core Infection Prevention and Control Practices: In addition to using NaDCC tablets, it’s critical to implement core infection prevention and control practices as outlined by the CDC [3]. These include assigning qualified individuals like Infection Preventionists to manage the infection prevention program, providing job-specific infection prevention education and training to all healthcare personnel, ensuring patient, family, and caregiver education on infection prevention, monitoring adherence to infection prevention practices, and using standard precautions to care for all patients. Standard precautions include hand hygiene, environmental cleaning and disinfection, injection and medication safety, and the appropriate use of personal protective equipment.
Reference:
[2] https://www.nadcctablet.com/
[3] https://www.cdc.gov/infectioncontrol/guidelines/core-practices/index.html
Contact our infection prevention experts for further guidance on NaDCC applications:
Dan Mueller
M/ 206.741.2981
Chirs Butler
M/ 781.364.7320
